Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Furlan

Showing results (31-40 of 225) with videos related to

Pageof 23
Sort By:
Frontiers in Immunology|November 19, 2021
HIV-1 Env Does Not Enable the Development of Protective Broadly Neutralizing Antibodies in an Experimental Autoimmune Encephalomyelitis Mouse ModelGabriel Siracusano, Annamaria Finardi, Claudia Pastori, et al.
Frontiers in Neurology|June 27, 2022
PD-1/PD-L Axis in Neuroinflammation: New InsightsSusanna Manenti, Mario Orrico, Stefano Masciocchi, et al.
Neurochemical Research|February 3, 2018
PDGF Modulates Synaptic Excitability and Short-Latency Afferent Inhibition in Multiple SclerosisDalila Mango, Robert Nisticò, Roberto Furlan, et al.
Current Neuropharmacology|August 28, 2025
Pharmacodynamics and Pharmacokinetics of Ublituximab Compared with Other Anti-Cd20 Monoclonal Antibodies for Multiple Sclerosis TreatmentMonica Margoni, Luca Battistini, Diego Centonze, et al.
Clinical Chemistry and Laboratory Medicine|March 14, 2026
Translating neurofilament light chain testing into clinical practice: a multidisciplinary implementation roadmapRoberto Furlan, Alessia Di Sapio, Diana Ferraro, et al.
Journal of Extracellular Vesicles|February 1, 2022
The impact of storage on extracellular vesicles: A systematic studyStefano Gelibter, Giulia Marostica, Alessandra Mandelli, et al.
Journal of Neuroimmunology|September 11, 2018
Calcitonin gene-related peptide decreases IL-1beta, IL-6 as well as Ym1, Arg1, CD163 expression in a brain tissue context-dependent manner while ameliorating experimental autoimmune encephalomyelitisIlaria Rossetti, Laura Zambusi, Annamaria Finardi, et al.
Journal of Neuroimmunology|February 13, 2010
Rapamycin inhibits relapsing experimental autoimmune encephalomyelitis by both effector and regulatory T cells modulationMarianna Esposito, Francesca Ruffini, Matteo Bellone, et al.
Frontiers in Neurology|June 16, 2015
Microvesicles: What is the Role in Multiple Sclerosis?Tiziana Carandini, Federico Colombo, Annamaria Finardi, et al.
Current Neuropharmacology|December 20, 2021
Vaccination Opportunities in Multiple Sclerosis Patients Treated with Cladribine TabletsLucia Moiola, Agostino Riva, Ferdinando Nicoletti, et al.
Pageof 23

Showing results (31-40 of 225) with videos related to

Sort By:
Pageof 23
Frontiers in Immunology|November 19, 2021
HIV-1 Env Does Not Enable the Development of Protective Broadly Neutralizing Antibodies in an Experimental Autoimmune Encephalomyelitis Mouse ModelGabriel Siracusano, Annamaria Finardi, Claudia Pastori, et al.
Frontiers in Neurology|June 27, 2022
PD-1/PD-L Axis in Neuroinflammation: New InsightsSusanna Manenti, Mario Orrico, Stefano Masciocchi, et al.
Neurochemical Research|February 3, 2018
PDGF Modulates Synaptic Excitability and Short-Latency Afferent Inhibition in Multiple SclerosisDalila Mango, Robert Nisticò, Roberto Furlan, et al.
Current Neuropharmacology|August 28, 2025
Pharmacodynamics and Pharmacokinetics of Ublituximab Compared with Other Anti-Cd20 Monoclonal Antibodies for Multiple Sclerosis TreatmentMonica Margoni, Luca Battistini, Diego Centonze, et al.
Clinical Chemistry and Laboratory Medicine|March 14, 2026
Translating neurofilament light chain testing into clinical practice: a multidisciplinary implementation roadmapRoberto Furlan, Alessia Di Sapio, Diana Ferraro, et al.
Journal of Extracellular Vesicles|February 1, 2022
The impact of storage on extracellular vesicles: A systematic studyStefano Gelibter, Giulia Marostica, Alessandra Mandelli, et al.
Journal of Neuroimmunology|September 11, 2018
Calcitonin gene-related peptide decreases IL-1beta, IL-6 as well as Ym1, Arg1, CD163 expression in a brain tissue context-dependent manner while ameliorating experimental autoimmune encephalomyelitisIlaria Rossetti, Laura Zambusi, Annamaria Finardi, et al.
Journal of Neuroimmunology|February 13, 2010
Rapamycin inhibits relapsing experimental autoimmune encephalomyelitis by both effector and regulatory T cells modulationMarianna Esposito, Francesca Ruffini, Matteo Bellone, et al.
Frontiers in Neurology|June 16, 2015
Microvesicles: What is the Role in Multiple Sclerosis?Tiziana Carandini, Federico Colombo, Annamaria Finardi, et al.
Current Neuropharmacology|December 20, 2021
Vaccination Opportunities in Multiple Sclerosis Patients Treated with Cladribine TabletsLucia Moiola, Agostino Riva, Ferdinando Nicoletti, et al.
Pageof 23